Skip to Content

M GP5 (Glipizide Extended-Release 5 mg)

Pill with imprint M GP5 is White, Round and has been identified as Glipizide Extended-Release 5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M GP5

Glipizide extended-release 5 mg M GP5

Glipizide Extended-Release

Imprint
M GP5
Strength
5 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Sulfonylureas
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-0342

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.